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Background: The human IgG4 antibody subclass does not activate complement and forms half-antibodies.
Results: Ultracentrifugation and x-ray/neutron scattering together with atomistic modeling revealed asymmetric concentra-
tion-dependent IgG4 solution structures.
Conclusion: The complement and receptor Fc binding sites are hindered by the Fab regions, explaining loss of activity.
Significance: These solution structures clarify IgG4 function and its therapeutic applications.
Human IgG4 antibody shows therapeutically useful prop-
erties compared with the IgG1, IgG2, and IgG3 subclasses.
Thus IgG4 does not activate complement and shows confor-
mational variability. These properties are attributable to its
hinge region, which is the shortest of the four IgG subclasses.
Using high throughput scattering methods, we studied the
solution structure of wild-type IgG4(Ser222) and a hinge
mutant IgG4(Pro222) in different buffers and temperatures
where the proline substitution suppresses the formation of
half-antibody. Analytical ultracentrifugation showed that
both IgG4 forms were principally monomeric with sedimen-
tation coefficients s20,w0 of 6.6–6.8 S. A monomer-dimer
equilibrium was observed in heavy water buffer at low tem-
perature. Scattering showed that the x-ray radius of gyration
Rg was unchanged with concentration in 50–250 mM NaCl
buffers, whereas the neutron Rg values showed a concentra-
tion-dependent increase as the temperature decreased in
heavy water buffers. The distance distribution curves (P(r))
revealed two peaks,M1 andM2, that shifted below 2mg/ml to
indicate concentration-dependent IgG4 structures in addi-
tion to IgG4 dimer formation at high concentration in heavy
water. Constrained x-ray and neutron scattering modeling
revealed asymmetric solution structures for IgG4(Ser222)
with extended hinge structures. The IgG4(Pro222) structure
was similar. Both IgG4 structures showed that their Fab
regions were positioned close enough to the Fc region to
restrict C1q binding. Our newmolecularmodels for IgG4 explain
its inability to activate complement and clarify aspects of its stabil-
ity and function for therapeutic applications.
IgG4 is the only human IgG antibody subclass that does not
activate complement (1) and is able to undergo Fab-arm
exchange (2) and associate with other IgG molecules via its Fc
region (3). Interest in IgG4 arises from its distinct properties
compared with the other human IgG subclasses IgG1, IgG2,
and IgG3 (4) and its desirability as a pharmaceutical (5).
Although the specific function of each IgG subclass remains to
be defined, different antigens (e.g. protein, polysaccharide, and
allergen) activate varied responses from the four IgG sub-
classes. IgG4 plasma levels rise after prolonged antigen expo-
sure, leading to anti-inflammatory effects (6). Fab-arm
exchange causes IgG4 to behave as if it were monovalent (7), in
turn preventing the cross-linking of antibody-antigen com-
plexes and explaining the anti-inflammatory effects of IgG4.
IgG4 is popular as a therapeutic as it does not activate comple-
ment. However, IgG4 drug products can perform Fab-arm
exchange with endogenous IgG4, limiting their efficacy (8).
IgG4 can bind to each of the Fc receptor subclasses; however, it
does so weakly in comparison with other subclasses (9).
IgG4 Fab-arm exchange is mediated through the Fc region
(hinge, CH2, and CH3 domains) (10) in which the separation of
the two heavy chains to form half-antibodies (half-mers) is
attributed to Ser222 in its core hinge region (supplemental Fig.
S1). Cys220 and Cys223 in the core hinge form disulfide bridges
between the heavy chains. Mutation of Ser222 to Pro222 by
genetic engineering gives an IgG1-like core hinge and elim-
inates half-mer formation (11). Conformational modeling on
the two core hinge peptides predicted that the wild-type
IgG4(Ser222) hinge is more flexible than the mutant
IgG4(Pro222) hinge, perhaps explaining the formation of sta-
ble intrachain disulfide bonds in the mutant (12). The equi-
librium between these disulfide bridges leads to heterogene-
ous IgG4 populations, each with two different heavy chains
(13). The kinetic rates of half-mer formation in vitro are very
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low, and Fab-arm exchange does not readily occur. This slow
exchange is attributed to strong non-covalent contacts
between the CH3 domains. In fact Fab-arm switching is
observed predominantly in vivo.
Fab-arm exchange has been clarified by mutagenesis studies
that showed Arg409 to be crucial for stabilizing the CH3-CH3
interaction (Arg403 in supplemental Fig. S2G) (14–16). Fab-
arm switching might be facilitated by protein-disulfide isomer-
ase or binding to the Fc receptor FcRn2 (4). It has now been
shown that Fab-arm exchange requires a combination of fac-
tors, predominantly theCH3 domains and the hinge region, and
the presence of a reducing environment; adjuvants are not nec-
essary. IgG1 undergoes Fab-arm switching after replacement
of the IgG1CH3 domain by the IgG4CH3 domain, showing that
the IgG4CH3 domain is crucial for exchange (17). Interestingly,
the Fab regions stabilize the intact IgG4 structure (18). The
ability of IgG4 to self-associate is also of interest. IgG4-Fc can
interactwith IgG1-Fcwhen IgG1 is coupled to a solid support; the
coupling of IgG1 is thought to induce a conformational change,
allowing accessibility of its IgG1-Fc for IgG4 binding (3).
An understanding of IgG4 would be facilitated by its atomis-
tic solution structure. Atomistic antibody structures are deter-
mined using our joint strategy of x-ray and neutron scattering
coupled with analytical ultracentrifugation and constrained
modeling based on crystal structures (19–21). Joint x-ray and
neutron scattering allows the study of a broad range of different
solution conditions, and this is facilitated by the ability to per-
form x-ray measurements in seconds rather thanminutes. Pre-
viously IgG4(Ser222) had been studied by ultracentrifugation
and x-ray scattering to show that IgG4 undergoes a concentra-
tion-dependent Fab-arm rearrangement (20). This concentra-
tion dependence is explored here using more detailed solution
structural data for both IgG4(Ser222) and IgG4(Pro222). We
show that IgG4(Ser222) and IgG4(Pro222) are principally mono-
meric, but IgG4(Ser222) shows self-associative behavior in
heavy water. Both forms display concentration-dependent
structural changes corresponding to Fab-arm rearrangements
at low concentrations. Both the IgG4(Ser222) and IgG4(Pro222)
solution structures display extended asymmetric arrangements
of the Fab regions relative to the Fc region.Our three independ-
ently determined IgG4 solution structures showed that the Fab
regions were close enough to the Fc region to hinder the C1q
and FcR binding sites at the top of the Fc region in IgG4. The
implications of this result for the reduced immune reactivity of
IgG4 are discussed.
EXPERIMENTAL PROCEDURES
Purification and Composition of IgG4—A wild-type human-
mouse chimera, IgG4 B72.3 with Ser222, was generously sup-
plied byDr. JimDavies (LonzaBiologics) (supplemental Figs. S1
and S2). Other studies named Ser222 as Ser228 (22), Ser229 (12),
and Ser241 (23). A mutant IgG4 with Pro222 was generously
supplied by Dr. Bryan Smith (UCB) (24). Both IgG4(Ser222) and
IgG4(Pro222) were further purified by gel filtration to remove
nonspecific aggregates using a Superose 6 10/300 column (GE
Healthcare), concentrated using an Amicon Ultra spin concen-
trator (50-kDa-molecular mass cutoff), and dialyzed at 4 °C
against the measurement buffer (see below). The sequence
identity between both IgG4 molecules was 100% for the CH1,
CH2, andCH3 domains (except for the S222P substitution). Dif-
ferent identities were found for the VH (67.5%), VL (59.3%), and
CL (96.2%) domains, giving an overall identity between the two
IgG4 sequences of 86.7% (supplemental Fig. S2). The N-linked
oligosaccharides at Asn291 on the CH2 domains (supplemental
Fig. S2) were assumed to be a complex-type biantennary oligo-
saccharide structure with a Man3-GlcNAc2 core and two
NeuNAc-Gal-GlcNAc antennae (25, 26). The IgG4(Ser222)
molecular mass was calculated to be 147.0 kDa, its unhydrated
volume was 188.7 nm3, its hydrated volume was 248.7 nm3
(based on a hydration of 0.3 g of water/g of glycoprotein and an
electrostricted volume of 0.0245 nm3 per bound water mole-
cule), its partial specific volume v was 0.728 ml/g, and its
absorption coefficient was 14.5 (1%, 1-cm pathlength, 280 nm).
For IgG4(Pro222), the molecular mass was 149.5 kDa, v was
0.728 ml/g, and the absorption coefficient was 14.1 (27).
All data were recorded in phosphate-buffered salinewith dif-
ferent NaCl concentrations. That termed PBS-137 comprised
137 mM NaCl, 8.1 mM Na2HPO4, 2.7 mM KCl, and 1.5 mM
KH2PO4 (pH 7.4). Buffers containing 50 mM NaCl or 250 mM
NaCl in place of 137 mM NaCl were termed PBS-50 and PBS-
250, respectively. The buffer densities were measured using an
Anton Paar DMA 5000 density meter for comparison with the
theoretical values from SEDNTERP (28). Measured densities
were 1.00544 g/ml for PBS-137 at 20 °C (theoretical, 1.00534
g/ml), 1.00176 g/ml for PBS-50 at 20 °C (theoretical, 1.00175
g/ml), and 1.01029 g/ml for PBS-250 at 20 °C (theoretical,
1.00998 g/ml). For PBS-137 in heavy water, recorded values
were 1.113137 g/ml at 6 °C, 1.11238 g/ml at 20 °C, and 1.109986
g/ml at 30 °C.
Sedimentation Velocity Data for IgG4—Analytical ultracen-
trifugation data for both IgG4 forms were obtained on two
Beckman XL-I instruments equipped with AnTi50 rotors. Sed-
imentation velocity data were acquired for IgG4(Ser222) sam-
ples in PBS-50, PBS-137, and PBS-250 at 20 °C; in PBS-137 at 6,
20, and 30 °C; and in PBS-137 with 100% 2H2O. Data were col-
lected at rotor speeds of 40,000 and 50,000 rpm in two-sector
cells with column heights of 12 mm. Sedimentation velocity
data were acquired for IgG4(Pro222) in PBS-137 at 20 °C only.
Data were collected at rotor speeds of 30,000, 40,000, 50,000,
and 60,000 rpm. Sedimentation analysis was performed using
direct boundary Lamm fits of up to 700 scans using SEDFIT
(version 12.1) (29, 30). SEDFIT resulted in size distribution
analyses c(s) that assume all species to have the same frictional
ratio f/f0. The final SEDFIT analyses used a fixed resolution of
200 and optimized the c(s) fit by floating f/f0 and the baseline
until the overall root mean square deviation and visual appear-
ance of the fits were satisfactory. The percentage of oligomers
in the total loading concentration was derived using the c(s)
integration function.
X-ray and Neutron Scattering Data for IgG4—X-ray scatter-
ing data were obtained during a single beam session in
16-bunch mode on Instrument ID02 at the European Synchro-
tron Radiation Facility, Grenoble, France, operating with a ring
2 Theabbreviationsusedare: FcR, Fc receptor;NeuNAc,N-acetylneuraminic acid;
Rg, radius of gyration; RXS, radius of gyration of cross-sectional structure.
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energy of 6.0 GeV (31). Data were acquired using a fiber opti-
cally coupled high sensitivity and dynamic range charge-cou-
pled device detector (FreLoN) with a resolution of 512  512
pixels. A sample-to-detector distance of 3.0 m was used.
IgG4(Ser222) in PBS-50, PBS-137, and PBS-250 was studied at
20 °C at eight concentrations between 0.48 and 6.91 mg/ml
(3.3–47M) in which 100-l samples were measured in a poly-
carboxylate capillary (2-mm diameter) that avoids protein
deposits during beam exposures. The sample was moved con-
tinuously during beam exposure to eliminate radiation damage.
Sets of 10 time frames, each of duration 0.1 or 0.2 s/frame, were
acquired in quadruplicate as a control of reproducibility.
Online checks during data acquisition confirmed the absence of
radiation damage after which the 10 frames were averaged. In
the same beam session, IgG4(Pro222) in PBS-137 at 20 °C was
studied at concentrations between 0.5 and 2.0 mg/ml (3.3-
13.4 M).
Neutron scattering data were obtained on Instrument
SANS2D at the ISIS pulsed neutron source at the Rutherford
Appleton Laboratory, Didcot, UK (32). A pulsed neutron beam
was derived from proton currents of40A. SANS2D scatter-
ing and transmission data were recorded with a collimation of
4 m, a sample-to-detector distance of 4 m, a beam diameter of
12 mm, and a wavelength range of 0.175–1.65 nm that was
determined by time of flight. IgG4(Ser222) samples were mea-
sured in 2-mm-path length circular banjo cells in a thermo-
stated rack at 20 °C as well as at 6 and 37 °C. Data acquisitions
lasted 1–2 h for four samples at concentrations between 2.0
(14 M) and 8.0 mg/ml (55 M) in PBS-137 prepared in 100%
heavy water.
In a given solute-solvent contrast, the radius of gyration Rg is
a measure of structural elongation if the internal inhomogene-
ity of scattering densities within the protein has no effect.
Guinier analyses at low Q (where Q  4 sin /; 2 is the
scattering angle, and  is the wavelength) gives the Rg and the
forward scattering at zero angle I(0) (33).




This expression is valid in a QRg range up to 1.5. If the
structure is elongated, the mean radius of gyration of cross-
sectional structure RXS and the mean cross-sectional inten-






For immunoglobulins, the cross-sectional plot exhibits two
regions, a steeper innermost region and a flatter outermost region
(34), identified by RXS-1 and RXS-2, respectively. The Rg and RXS
analyseswereperformedusingan interactivePERLscriptprogram
SCTPL73 on Silicon Graphics OCTANEWorkstations. Indirect
transformation of the scattering data I(Q) in reciprocal space
into real space to give the distance distribution function P(r)







I(Q)Qr sin(Qr) dQ (Eq. 3)
P(r) corresponds to the distribution of distances r between all
volume elements. This yields the maximum dimension of the
macromolecule L and its most commonly occurring distance
vector M in real space. To calculate this, the x-ray I(Q) curve
utilized up to 341 data points in the Q range between 0.03 and
1.60 nm	1. The neutron I(Q) curve utilized up to 112 data
points in the Q range between 0.01 and 2.0 nm	1.
Debye Scattering and Sedimentation Coefficient Modeling of
IgG4—Atotal of 20,000 conformationally randomized full sized
IgG4(Ser222) models were created by joining molecular struc-
tures for the IgG4 Fab and Fc regions. A homology model for
human IgG4 was constructed from crystal structures for Fab
B72.3 and human IgG1 (Protein Data Bank codes 1BBJ and
1HZH) (36, 37) as described previously (20). Four sets of 5000
randomized IgG4 models were created using different hinge
lengths and compositions. Two sets of asymmetricmodelswere
based on the IgG1 crystal structure. For these, a 9-residue hinge
peptide, 212VESKYGPPC220, was constrained to be of a mini-
mum length between 2.2 and 3.1 nm or 3.1 and 3.15 nm
where the latter is almost fully extended in length. As Cys220
is located asymmetrically relative to the Fc structure, all
these models were conformationally asymmetric. Because
this asymmetry may be a crystallographic artifact, two sets
of symmetric models were created. For these, a 21-residue
hinge peptide, 212VESKYGPPCPSCPAPEFLGGP232, that
encompassed the whole hinge was constrained to be of a
minimum length between 5.0 and 7.0 nm or between 7.0 and
7.35 nm where the latter is almost fully extended in length.
Because Pro232 is located symmetrically in relation to the Fc
structure, the resulting IgG4 models contained Fab regions
in both symmetric and asymmetric orientations. The outer-
most hinge residues were anchor points used to superimpose
each hinge conformation onto the Fab and Fc regions to
create the full-length IgG4model. For each of the four sets of
5000 IgG4 models, two different hinge conformations were
randomly selected to join the two Fab and Fc regions to form
IgG4.
The scattering curve was calculated from each IgG4 model
using sphere models. A cube side of 0.557 nm and a cutoff of
four non-hydrogen atomswas used to convert the atomic coor-
dinates into 1142 spheres that corresponded to the unhydrated
structure seen by neutron scattering. Because hydration shells
are visible by x-rays, a hydration shell corresponding to 0.3 g of
water/g of protein was created using HYDRO (38), giving an
optimal total of 1468 spheres. The x-ray scattering curve I(Q)
was calculated using the Debye equation adapted to spheres
(39). Details are given elsewhere (26, 40). Steric overlap
between the Fab and Fc regions was assessed using the number
of spheres n in eachmodel wheremodels showing less than 95%
of the required total of 1468 spheres (x-ray) or 1142 spheres
(neutrons) were discarded. Of the 20,000 hydratedmodels, 82%
showed no steric overlap. The x-ray Rg, RXS-1, and RXS-2 values
were calculated from the modeled curves in the same Q ranges3 J. T. Eaton and S. J. Perkins, unpublished software.
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used for the experimental Guinier fits. Models that passed Rg
and RXS filters of 5% of the experimental value were then
ranked using a goodness-of-fit R-factor (defined by analogy
with protein crystallography) in the Q range extending to 1.6
nm	1. For the neutronmodeling, 84% of the 20,000 unhydrated
sphere models showed no steric overlap. The neutron models
were assessed as for the x-ray scattering models above with
corrections for wavelength spread and beamdivergence, but no
correction was required for a flat background caused from
incoherent scattering because of the extrapolation to zero
concentration.
Sedimentation coefficients (s20,w0 ) were calculated directly
from the hydrated Debye sphere models using the program
HYDRO (41). They were also calculated from the atomic coor-
dinates in the HYDROPRO shell modeling program using the
default value of 0.31 nm for the atomic element radius for all
atoms to represent the hydration shell (42). Previous applica-
tions of these calculations to antibodies are reviewed elsewhere
(43).
The outcome of the fit searches was evaluated by calculating
the distances between the centers of mass of the Fab-Fc and
Fab-Fab pairs (d1, d2, and d3; excluding hydrogen atoms) using
a Python script. The three angles between the Fab and Fc
regions were also calculated; these were defined in a Python
script as the angle of intersection from the dot product between
two vectors. Each vector was defined as the long axis through
each Fab or Fc region, each defined as the line passing through
the centers of gravity between each cluster of four cysteine
-carbon atoms at the two ends of the Fab and Fc regions. One
cluster at each end of each Fab or Fc region corresponded to the
conserved disulfide bridge in each immunoglobulin fold
domain. Artwork was prepared using PyMOL (Schro¨dinger,
LLC). The Fc regions in the 10 best fit IgG4models were super-
imposed using the align function within PyMOL. To dock the
crystal structures for the Fc region and the C1q head (19), the
web server algorithm PatchDock (version beta 1.3) was used to
include specified residues as potential binding sites, and then
the output was refined using FireDock from the same web site
(44).
Protein Data Bank Accession Numbers—The three sets of 10
best fitmodels are currently available as supplementalmaterial.
They have been deposited in the Protein Data Bank under
accession codes 4PTO (IgG4(Ser222) in PBS-137), 4PTQ
(IgG4(Ser222) in PBS-137 in 2H2O), and 4PTR (IgG4(Pro222) in
PBS-137).
RESULTS
Purification of Human IgG4—Wild-type IgG4(Ser222) and its
mutant IgG4(Pro222) were subjected to gel filtration to ensure
monodispersity immediately prior to the ultracentrifugation
and scattering experiments. Both molecules eluted as a sym-
metric main peak at 16 ml (supplemental Fig. S3) and showed a
single band between 200 and 116 kDa in non-reducing SDS-
PAGE that corresponds to the expected masses of 147.0 and
149.5 kDa for intact IgG4(Ser222) and IgG4(Pro222), respec-
tively. Under reducing conditions, the heavy chains for both
IgG4 molecules were observed at an apparent molecular mass
of 55 kDa, and their light chains were between 31 and 21.5 kDa,
both as expected (supplemental Fig. S3).
Analytical Ultracentrifugation of Human IgG4—Sedimenta-
tion velocity experiments examined the size and shape of
IgG4(Ser222) between 0.5 and 8 mg/ml and IgG4(Pro222)
between 0.5 and 2.5 mg/ml. The SEDFIT analyses in different
NaCl buffers in H2O and at different temperatures in 2H2O
buffers involved fits of as many as 700 scans, and the good
agreement between the experimental boundary scans and fitted
lines is clear (Fig. 1, A–C). A major monomer peak was
observed at s20,w0 values of 6.8 S for IgG4(Ser222) and 6.6 S for
IgG4(Pro222). These s20,w0 values are consistentwith the range of
values (6.2–6.9 S) reported previously for human IgG4 (20,
45–48). Accordingly both IgG4(Ser222) and IgG4(Pro222) were
predominantly monomeric in solution and were accompanied
by a minor dimer peak.
From the c(s) analyses, themolecularmasses of themonomer
peak for IgG4(Ser222) were reported as 144 (PBS-50), 145 (PBS-
137), and 141 kDa (PBS-250) in light water and 171 (PBS-137 at
6 °C), 149 (PBS-137 at 20 °C), and 145 kDa (PBS-137 at 30 °C) in
heavy water. These agree well with the composition-calculated
mass of 147 kDa with the exception of PBS-137 in heavy water
at 6 °C. However, for PBS-137 in heavy water at 6 °C, a reaction
boundary was observed from the concentration dependence of
its monomer peak (Fig. 1B). The molecular mass of the
IgG4(Pro222) monomer peak was measured as 143 kDa (PBS-
137) in agreement with the composition-calculated mass of
150 kDa.
The apparent sedimentation rates of the IgG4 monomer
depended on the buffer composition and temperature (Fig. 1,
A–C). The monomer s20,w value decreased slightly with rotor
speed. For IgG4(Ser222), themonomer s20,w0 value was 6.76 S for
40,000 rpm, decreasing to 6.68 S for 50,000 rpm for PBS-137 at
20 °C. For IgG4(Pro222), themonomer s20,w0 value was 6.64 S for
30,000 rpm, decreasing to 6.59 S for 40,000 rpm, 6.56 S for
50,000 rpm, and 6.53 S for 60,000 rpm. All the IgG4 data
reported in this study are for 40,000 rpm. Extrapolation of the
s20,w values to zero concentration gavemonomer s20,w0 values of
6.71, 6.76, and 6.64 S for the PBS-50, PBS-137, and PBS-250
buffers, respectively, in light water (Fig. 2A). In PBS-137 in
heavy water, the monomer sedimented at apparent rates of
2.75, 4.07, and 5.07 S at 6, 20, and 30 °C, respectively (Fig. 1B).
When corrected for the buffer density and viscosity of heavy
water, s20,w0 values of 6.49, 7.22, and 7.35 S, respectively, were
obtained. Given that the partial specific volume v for proteins is
affected by the hydration shell (27, 40) and that the hydration
shell for heavy water has a highermass than that for light water,
the v values will be reduced in 100% 2H2O. Additionally, the
hydration shell is affected by temperature as shown by the large
difference between the s20,w0 values at 6 and 30 °C. Thus v values
of 0.734, 0.716, and 0.713 ml/g were used for 6, 20, and 30 °C,
respectively, in place of 0.728 ml/g, and these gave final mono-
mer s20,w0 values of 6.76 S for each temperature, which are the
same as that for PBS-137 in light water. For IgG4(Pro222), the
s20,w0 value was 6.59 S for PBS-137 at 20 °C, which is not signif-
icantly different from that for IgG4(Ser222).
The c(s) analyses for IgG4(Ser222) revealed a minor dimer
peak at s20,w0 values between 9 and 10 S in the size distribution
Solution Structure of IgG4
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analyses c(s) (Figs. 1 and 2). Themolecularmasses in light water
were 259 16 (PBS-50), 270 11 (PBS-137), and 264 11 kDa
(PBS-250) and slightly larger in heavy water at 315 24 (PBS-
137 at 6 °C), 286  36 (PBS-137 at 20 °C), and 281  9 kDa
(PBS-137 at 30 °C). These masses are comparable with the
expected value of 294 kDa for the IgG4(Ser222) dimer.
IgG4(Pro222) also showed a small dimer peak of size 2–3% with
a s20,w0 value of 9.25  3.0 S and a molecular mass of 276  15
kDa. This agreed well with the predictedmass of 300 kDa for its
dimer. Themonomer anddimer c(s) peakswere integrated. The
amount of dimer did not alter with concentration or buffer
composition (Fig. 2B) and totaled between 1 and 3% dimer. The
monomer/dimer ratio corresponded to weak dissociation con-
stants (KD) in a range of 600–3000 M. In comparison, dimer
formation for rabbit IgG was noticeably higher with the corre-
spondingKD values ranging from 70M for PBS-137 at 20 °C in
heavy water to 350M in PBS-137 at 30 °C (19). The s20,w0 values
were similar in light water at 9.61 0.34 (PBS-50), 9.78 0.32
(PBS-137), and 9.71  0.36 S (PBS-250) at 20 °C. They were
slightly larger but similar at 10.27  0.70, 10.17  0.81, and
10.02  0.23 S at 6, 20, and 30 °C, respectively, in PBS-137 in
heavy water.
X-ray and Neutron Scattering of Human IgG4—The solution
structure of IgG4 was jointly analyzed by both x-ray and neu-
tron scattering for reproducibility. X-rays in light water buffers
monitor the hydration shell as well as the protein structure,
whereas neutrons in heavy water buffers monitor the unhy-
drated structure (see below).
X-rays were most effective for looking at IgG4 at 20 °C in
three different NaCl concentrations. X-ray data collection of
IgG4(Ser222) was carried out between 0.48 and 6.91 mg/ml
using time frame analyses to ensure the absence of radiation
damage effects. Guinier analyses resulted in high quality linear
plots in three distinct regions of the I(Q) curves, as expected for
antibodies, from which the Rg, RXS-1, and RXS-2 values were
obtainedwithin satisfactoryQRg andQRXS limits (supplemen-
tal Fig. S4A andTable 1). The x-rayRg values for IgG4(Ser222) in
PBS-50, PBS-137, and PBS-250 showed no concentration
dependence with mean values of 4.90, 4.92, and 4.96 nm,
respectively (Fig. 3A). The I(0)/c values for IgG4, which were
similar at 0.0192, 0.0181, and 0.0179, respectively, also showed
no concentration dependence (Fig. 3A). Each of the RXS-1 and
RXS-2 values were unchanged among PBS-50, PBS-137, and
PBS-250 with mean RXS-1 values of 2.53, 2.56, and 2.51 nm,
respectively, and mean RXS-2 values of 1.40, 1.37, and 1.33 nm,
respectively. These values agree with the Rg, RXS-1, and RXS-2
values of 4.99, 2.56, and 1.40 nm, respectively, for this same
human IgG4(Ser222) molecule in PBS-137 (20). For comparison
with IgG4(Ser222), IgG4(Pro222) was studied between 0.5 and
2.0 mg/ml in PBS-137 (supplemental Fig. S4C). The x-ray Rg
values showed no concentration dependencewith amean value
of 4.90 nm (Fig. 3C). Similarly, the I(0)/c values for IgG4(Pro222)
were 0.0191, showing no concentration dependence and in
agreement with those for IgG4(Ser222) (Fig. 3C). The mean
RXS-1 and RXS-2 values were unchanged at 2.60 and 1.37 nm,
respectively (Fig. 3C).
Neutron scattering studied the unhydrated protein structure
in which the hydration shell is almost invisible in heavy water
(40). Neutrons were most useful for temperature studies in
PBS-137 because temperature-dependent conditions were less
accessible by x-ray scattering. IgG4(Ser222) in 100% 2H2O
buffer was analyzed between 2.0 and 8.0 mg/ml. The Guinier
analyses revealed high quality linear fits for the same three
parameters, Rg, RXS-1, and RXS-2, as described above for x-rays
(supplemental Fig. S4B). The neutron Rg values increased with
increasing concentration from 5.16 to 5.82 nm at 6 °C, from
4.87 to 5.36 nm at 20 °C, and from 4.62 to 4.85 nm at 37 °C (Fig.
3B). TheseRg changes were comparatively large, indicating that
heavy water promoted IgG4 dimer formation. Because the neu-
tron Guinier fits go to smaller Q values than the x-ray Guinier
fits, the neutron fits were more sensitive to dimer formation
than the x-ray fits. Extrapolations to zero concentration
resulted in Rg values of 4.99 (6 °C), 4.77 (20 °C), and 4.67 nm
(37 °C). The corresponding I(0)/c values also increased (Fig.
3B). The neutron RXS-1 values decreased slightly with concen-
tration from 2.50 to 2.28 nm at 6 °C, from 2.43 to 2.30 nm at
20 °C, and from 2.50 to 2.33 nm at 37 °C (Fig. 3B). The RXS-2
values showed no concentration dependence with mean values
of 1.23, 1.23, and 1.17 nm at 6, 20, and 37 °C, respectively (Fig.
3B). The neutron Rg, RXS-1, and RXS-2 values were slightly
FIGURE 1. Sedimentation velocity analyses of human IgG4.A, on the left, the experimentally observed sedimentation boundaries for IgG4(Ser222) in PBS-50,
PBS-137, and PBS-250 in H2Owere recorded at a rotor speed of 40,000 rpm. B, IgG4(Ser
222) wasmeasured at 6, 20, and 30 °C in PBS-137 in 2H2O at a rotor speed
of 40,000 rpm. C, IgG4(Pro222) in PBS-137 in H2O was also measured at 40,000 rpm. Fifty boundaries (black outlines) are shown from as many as 700 scans at
intervals of every e.g. 14th scan for clarity. The SEDFIT fits are shown as white lines. On the right, the observed s values in the corresponding size distribution
analyses c(s) revealed a monomer (M) peak at s20,w
0 values of6.8 S for IgG4(Ser222) and 6.6 S for IgG4(Pro222) in the H2O buffers together with a minor dimer
peak (D) at about 9 S. The observed s values in 2H2O buffers are shifted to lower S values.
FIGURE 2. Concentration dependence of the IgG4 sedimentation analy-
ses. A, the concentration dependence of the s20,w values for the IgG4 mono-
mer and dimer peaks of Fig. 1 are shown as a function of IgG4(Ser222) concen-
tration. Themean s20,w values are shown as solid lines for PBS-50 (), PBS-137
(E), and PBS-250 () in H2Obuffer at 20 °C and as dotted lines for 6 (‚), 20 (E),
and 30 °C (ƒ) for PBS-137 at 20 °C in 2H2O buffer. Data for IgG4(Pro
222) () in
PBS-137 in H2O at 20 °C are shown as two dashed lines. B, the mean percent-
ages of the major monomer and minor dimer forms from integration of the
c(s) analyses are shown for PBS-50, PBS-137, and PBS-250 at 20 °C (solid lines)
and at 6, 20, and 30 °C for PBS-137 in 2H2O (dotted lines). Data for IgG4(Pro
222)
() in PBS-137 in H2O at 20 °C are shown as two dashed lines.
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smaller than the x-ray values, such as that of 4.92 nm for the Rg
value in PBS-137, and this reduction is attributed to the near
invisibility of the surface hydration shell in heavy water (40) as
well as the high negative solute-solvent contrast difference.
The distance distribution function P(r) provides structural
information on IgG4 in real space. The x-ray P(r) analyses gave
Rg and I(0)/c values for IgG4(Ser222) that were similar to those
from the x-ray Guinier analyses, showing that the two analyses
were self-consistent (Fig. 3A, filled and open symbols). The
maximum length L of IgG4 was determined from the value of r
when the P(r) curve intersects zero to be 16 nm for PBS-50,
PBS-137, and PBS-250 (Fig. 4A). Themaxima in the P(r) curves
correspond to the most frequently occurring interatomic dis-
tances within the structure. For IgG4(Ser222), two peaks, M1
and M2, were identified in many P(r) curves except for that of
the 0.5mg/ml P(r) curve where onlyM1was identified. TheM1
peak corresponds mostly to distances within each Fab and Fc
region, whereas the M2 peak corresponds mostly to distances
between pairs of Fab and Fc regions. No buffer dependence in
the positions of peaks M1 and M2 was observed. However, the
positions of theM2 peaks depended on the IgG4 concentration
below 2 mg/ml (Fig. 5A). The more extensive data sets of this
study confirmed this dependence seen previously with more
limited data (20). The concentration dependence was attrib-
uted to a rearrangement of the Fab regions in IgG4(Ser222) in
which a 1–2-nm change in the average separation between the
Fab-Fc pairs was deduced (20). At concentrations above 2
mg/ml, our newdata show that this effect is absentwithM1 and
M2 being at 4 and 7 nm, respectively (Fig. 5A). The
IgG4(Pro222) mutant also showed twoM1 andM2 peaks with a
similar pronounced shift in theM2 peak (but an unchangedM1
peak) with change in concentration, and the L value was
unchanged at 15 nm (Figs. 4C and 5C).
The neutron P(r) analyses reflected IgG4 dimer formation in
heavy water. The Rg and I(0)/c values for IgG4(Ser222) at 6, 20,
and 37 °C increased with increasing concentration (Fig. 3B).
This was attributed to dimer formation. This result is consis-
tent with the sedimentation velocity experiments where a reac-
tion boundary between monomer and dimer was observed in
heavy water at 6 and 20 °C (Fig. 1B) but not in light water. The
neutron L values were between 17 and 21 nm at 6 °C, 16 and 19
nm at 20 °C, and 15 and 16 nm at 37 °C (Fig. 4B). Thus the
greater proportion of dimer at lower temperatures resulted in
increased dimensions. Because low amounts of dimer are pres-
ent, the maximum length of the dimer is probably greater than
21 nm. The two peaks M1 and M2 were again identified at4
and 7 nm, respectively, in the neutron P(r) curves (Fig. 5B). The
positions of M1 and M2 were unchanged between 2 and 8
mg/ml in agreement with the x-ray P(r) data.
Starting Model for the Human IgG4 Scattering Fits—The
human IgG4 homologymodels were created from crystal struc-
tures for B72.3 Fab (36) and human IgG1 Fc (37). Details of the
sequence alignments, target and template sequence identities,
and structure validations are described elsewhere (20). The pre-
vious modeling of hinge libraries with 10,000 conformations
based on asymmetric IgG4 structures was now extended to
include libraries based on symmetric IgG4 structures (“Exper-
imental Procedures”). The full hinge is formally defined by the
residues 213ESKYGPPCPSCPAPEFLGGP232 (22) in which the
Fab region ends at Val212 and the Fc region starts at Ser233
TABLE 1
Modeling searches of the x-ray and neutron scattering and sedimentation coefficient data for human IgG4
Filter Models Spheresa Rgb RXS-1 RXS-2 Dmax R-factor s20,w
0 c
nm nm nm nm % S
X-ray data IgG4(Ser222)
in PBS-137
IgG4 x-ray models None 20,000 1047–1554 3.05–7.01 0.07–3.32 0.05–2.85 n.a. n.a. n.a.
X-ray fit, 0.48 mg/ml Rg, RXS, spheres 10 1455–1478 4.74–4.80 2.48–2.59 1.53–1.64 n.a. 4.0–4.1 6.88–6.99; 6.57–6.83
Experimental data n.a.d n.a. n.a. 4.99 0.23; 4.81 0.06 2.59 0.03 1.43 0.24 16 n.a. 6.76
X-ray fit, 0.96 mg/ml Rg, RXS, spheres 10 1460–1512 4.72–4.90 2.56–2.61 1.52–1.61 n.a. 3.1–3.2 6.83–6.93; 6.55–6.92
Experimental data n.a. n.a. n.a. 4.89 0.15; 4.90 0.09 2.63 0.04 1.47 0.14 16 n.a. 6.76
X-ray fit, 1.93 mg/ml Rg, RXS, spheres 10 1461–1501 4.71–4.93 2.50–2.66 1.24–1.34 n.a. 2.5–2.6 6.81–6.95; 6.58–6.79
Experimental data n.a. n.a. n.a. 4.83 0.02; 4.93 0.01 2.56 0.01 1.30 0.07 16 n.a. 6.76
X-ray fit, 3.86 mg/ml Rg, RXS, spheres 10 1451–1483 4.87–4.98 2.50–2.61 1.34–1.43 n.a. 2.7–2.9 6.76–6.91; 6.43–6.94
Experimental data n.a. n.a. n.a. 4.94 0.11; 4.98 0.06 2.51 0.03 1.38 0.02 16 n.a. 6.76
X-ray fit, 5.79 mg/ml Rg, RXS, spheres 10 1451–1496 4.82–4.98 2.48–2.61 1.34–1.45 n.a. 2.8–3.0 6.76–6.93; 6.42–6.94
Experimental data n.a. n.a. n.a. 5.04 0.05; 5.07 0.04 2.51 0.02 1.37 0.03 16 n.a. 6.76
Neutron data IgG4(Ser222)
in PBS-137
IgG4 neutron models None 20,000 862–1177 2.91–5.04 0.18–2.73 0.33–2.47 n.a. n.a. n.a.
Neutron fit, 0 mg/ml Rg, RXS, spheres 10 1131–1167 4.74–4.86 2.50–2.55 1.14–1.24 n.a. 2.5–2.7 7.15–7.37; 6.38–6.71
Experimental data n.a. n.a. n.a. 4.77 2.49 1.19 16 n.a. 6.76
X-ray data IgG4(Pro222)
in PBS-137
X-ray fit, 0.5 mg/ml Rg, RXS, spheres 10 1466–1494 4.92–5.04 2.61–2.69 1.38–1.48 n.a. 3.6–3.7 6.72–6.82; 6.23–6.69
Experimental data n.a. n.a. n.a. 4.97 0.02; 5.02 2.58 0.13 1.34 0.13 15 n.a. 6.59
X-ray fit, 1.0 mg/ml Rg, RXS, spheres 10 1402–1473 4.75–4.93 2.52–2.63 1.29–1.40 n.a. 3.4–3.6 6.84–7.02; 6.60–6.84
Experimental data n.a. n.a. n.a. 4.85 0.01; 4.90 2.60 0.07 1.32 0.03 15 n.a. 6.59
X-ray fit, 1.5 mg/ml Rg, RXS, spheres 10 1429–1476 4.75–4.97 2.59–2.64 1.33–1.44 n.a. 3.0–3.2 6.85–7.01; 6.48–6.84
Experimental data n.a. n.a. n.a. 4.84 0.01; 4.93 2.64 0.05 1.43 0.06 15 n.a. 6.59
X-ray fit, 2.0 mg/ml Rg, RXS, spheres 10 1429–1482 4.75–4.97 2.56–2.64 1.36–1.45 n.a. 3.0–3.2 6.78–7.01; 6.46–6.86
Experimental data n.a. n.a. n.a. 4.82 0.01; 4.92 2.60 0.02 1.40 0.03 15 n.a. 6.59
a The optimum number n of hydrated (x-rays) and unhydrated (neutrons) spheres predicted from the sequence was 1468 and 1142, respectively.
b The first experimental value is from the Guinier Rg analysis (Fig. 4), and the second is from the GNOM P(r) analysis (Fig. 5).
c The first modeled value corresponds to that from HYDRO, and the second is that from HYDROPRO.
d n.a., not applicable.
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(supplemental Figs. S1 and S2). The IgG4 hinge contains six Pro
residues and two Cys220 and Cys223 disulfide bridges. The
asymmetric modeling considered only the upper hinge,
212VESKYGPPC220, with Val212 andCys220 acting as tethers. As
this hinge is located asymmetrically relative to the Fc region,
these 10,000 models do not have 2-fold symmetry. However,
the two interchain disulfide bonds are intact. The symmetric
modeling considered the upper, middle, and lower hinge, and
this resulted in a 21-residue peptide, 212VESKYGPPCPSCPA-
PEFLGGP232. Because the two Pro232 residues were located in
the middle of the Fc region, this approach generated both sym-
metric and asymmetric models. For these 10,000 further mod-
els, the Cys220 and Cys223 interchain disulfide bonds were not
kept intact.
Conformational Searches for the Human IgG4 Solution
Structure—To model the IgG4(Ser222) and IgG4(Pro222) solu-
tion structures, 20,000 conformationally randomized IgG4
structures were created from the Fab and Fc structures starting
from four conformational libraries of randomized hinge pep-
tides of lengths 2.2–3.1 and 3.1–3.15 nm (asymmetric) and 5.0–
7.0 and 7.0–7.35 nm (symmetric) (“Experimental Procedures”).
Each modeled scattering curve was compared with the experi-
mental x-ray and neutron scattering curves. The nine x-ray
curves included IgG4(Ser222) in PBS-137 at concentrations of
0.48, 0.96, 1.93, 3.86, and 5.79 mg/ml and IgG4(Pro222) in PBS-
137 at concentrations of 0.5, 1.0, 1.5, and 2.0 mg/ml. These
curve fits investigated whether molecular models could ration-
alize the conformational change seen in IgG4 at below 2mg/ml
for the wild-type and mutant forms of IgG4 (Fig. 5, A and C).
FIGURE 3. Concentration and temperature dependences of the x-ray and
neutron Guinier analyses. A, the x-ray Guinier values for IgG4(Ser222) were
measured in quadruplicate and averaged and are shown as the mean S.D.
All the lines show themean value. Error bars representing S.D. are shown only
when larger than the symbol. The x-ray Rg values for IgG4(Ser
222) are shown
for PBS-50 ( and f), PBS-137 (E and F), and PBS-250 ( and). The open
symbols correspond to the Guinier values, and the filled symbols correspond
to the P(r) values. The corresponding x-ray I(0)/c, RXS-1, and RXS-2 values are
likewise shown for the three buffers. B, the neutron values correspond to
single measurements in PBS-137 in 2H2O. The lines correspond to linear
regression fits. The Rg values at 6 (ƒ and), 20 (E andF), and 37 °C (‚ andŒ)
are shown with the open symbols corresponding to the Guinier values and
filled symbols corresponding to the P(r) values. The corresponding I(0)/c,RXS-1,
and RXS-2 values are likewise shown. The fitted line shown for RXS-2 is themean
value.C, the correspondingx-rayGuinier values for IgG4(Pro222) () are shown
in the same view as that of A.
FIGURE 4. X-ray and neutron distance distribution analyses P(r) for IgG4.
ThepeakmaximaatM1andM2and themaximumlengthat Lare indicatedby
arrows. A, the x-ray P(r) curves for IgG4(Ser222) in PBS-50, PBS-137, and PBS-
250are shownat concentrationsbetween0.5 and6mg/ml.B, theneutronP(r)
curves for IgG4(Ser222) in PBS-137 in 2H2O buffer at 6, 20, and 37 °C are shown
for concentrations between 2 and 8 mg/ml. C, the x-ray P(r) curves for
IgG4(Pro222) in PBS-137 are shown for concentrations between 0.5 and 2
mg/ml.
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Because IgG4 dimerizes in heavy water, neutron curve fits
were based on linear extrapolation of the four experimental
curves for IgG4(Ser222) to zero concentration (Fig. 3B). This
curve fit examined a single conformation for the IgG4 mon-
omer only. The 10 fit searches were assessed in R-factor
versus Rg graphs (Fig. 6). In all 10 searches, the occurrence of
a single minimum in the R-factor values identified a single
family of solution structures for IgG4 starting from a wide
range of orientations and translations of the two Fab and Fc
regions. The lowest R-factors in the 20,000 curve fits corre-
sponded to modeled Rg values close to the experimental Rg
values as desired.
Filters were used to identify the 10 best fit models for each
search. (i) A5% filter for steric overlap eliminated models in
which the Fab and Fc regions sterically overlapped with each
other because of inappropriate hinge conformations. Tomatch
the composition-calculated volume of IgG4, sphere models
needed a minimum number n of 1468 spheres for the hydrated
x-ray models and 1142 spheres for the unhydrated neutron
models. (ii) A 5% filter for the modeled Rg values (calculated
from the same Q ranges used for the experimental analyses)
identified the models that agreed best with the experimental
x-ray or neutron Rg values. (iii) The models that passed the n
and Rg filters were arranged in order of their lowest R-factors.
The resulting 10 best fit models for IgG4 were found as a single
cluster at the R-factor minimum in each of the 10 searches (Fig.
6, green).
The two interchain disulfide bonds at Cys220 andCys223 were
explicitly conserved in the asymmetric models. For the sym-
metric models, the pairs of Cys220 and Cys223 residues may no
longer be proximate. Their -carbon separations were 1.02–
3.29 nm for Cys220 and 1.20–2.43 nm for Cys223 in IgG4(Ser222)
by x-rays, 0.75–2.18 nm forCys220 and 0.98–1.99 nm forCys223
in IgG4(Pro222) by x-rays, and 2.02 nm for Cys220 and 1.98 nm
for Cys223 for IgG4(Ser222) by neutrons. These -carbon sepa-
rations were comparable with an expected-carbon separation
of 0.4–0.75 nm between two bridged Cys residues (49).
The best fit modeled curves showed good visual scattering
I(Q) and P(r) curve fits in all 10 cases with the experimental
curves (Fig. 7). For each case, the Rg values for the 10 best fit
models were within error of the experimental values (Table 1).
The 10 sets of models in Fig. 8 generally displayed asymmetric
arrangements of the two Fab regions compared with the Fc
region. Although IgG4(Ser222) showed slightly higher propor-
tions of asymmetric structures compared with the asymmetric
and symmetric arrangements seen for IgG4(Pro222), there were
no significant differences between the wild-type and mutant
structures. Unlike our previous study (20), no gradual contin-
uum between the models at different concentrations was now
seen. Surveys of the distances between the centers of the Fab
and Fc regions in the best fit IgG4(Ser222) x-ray and neutron
models and in the IgG4(Pro222) x-ray models (Figs. 6 and 8)
showed similar distributions (supplemental Fig. S5). The x-ray
R-factor values for the best fit IgG4 models (Fig. 6, pink) were
acceptable at 2.5–4.0% for IgG4(Ser222) and 3.0–3.6% for
IgG4(Pro222) (Table 1). The neutron R-factor values were
acceptable at 2.5–2.7%. These R-factor values are comparable
with those from other similar modeling fits (43).
Sedimentation Coefficient Modeling of Human IgG4—The
s20,w0 values of each of the nine sets of scattering best fit hydrated
IgG4 models were calculated for comparison with the experi-
mental values of 6.76 S for IgG4(Ser222) and 6.59 S for
IgG4(Pro222) (Fig. 2A). For the best fit hydrated sphere models,
the s20,w0 values were 6.76–6.99 and 6.72–7.02 S for
IgG4(Ser222) and IgG4(Pro222), respectively, using HYDRO
(Table 1). For the best fit molecular models, the s20,w0 values
were 6.42–6.94 and 6.23–6.84 S for IgG4(Ser222) and
IgG4(Pro222), respectively, using HYDROPRO (Table 1). Given
that the calculations should be accurate to within0.21 S (43),
both sets ofmodeled s20,w0 values agreewell with the experimen-
tal values.
DISCUSSION
The large body of x-ray scattering data permitted a detailed
appraisal of the solution structure of human IgG4, and this was
supported by complementary neutron scattering and ultracen-
trifugation experiments. The scattering data enabled atomis-
tic conformational analyses of IgG4 that resulted in three
independent determinations of an asymmetric IgG4 solution
structure. The combination of the resulting three IgG4 solu-
tion structures with (i) a recent docking model for the inter-
action between human Fc and the crystal structure of the
C1q globular head (19, 50) and (ii) crystal structures for the
human Fc-Fc	R receptor (51, 52) has provided new clarity
on the lack of reactivity of human IgG4 with its two major
effector ligands.
IgG4 has the lowest IgG serum concentration of the four IgG
subclasses at an average level of 0.4 mg/ml (in a range of 0.2–1
mg/ml). The data collection of our IgG4 study utilized a con-
centration range of 0.4–8.0 mg/ml, which spanned the serum
range and above. IgG1 is themost common subclass at 8mg/ml
(in a range of 5–12 mg/ml) followed by 4 mg/ml for IgG2 (in a
FIGURE 5. Concentration dependence of the P(r) analyses for IgG4. A, the
x-ray values of the P(r) maxima M1 and M2 are shown for IgG4(Ser222) in
PBS-50 (M1, ; M2, ; dashed line), PBS-137 (M1, E; M2, F; solid line), and
PBS-250 (M1,; M2,f; dotted line). These are comparedwith the 2010 values
(20) for IgG4(Ser222) in PBS-137 (M1, open; M2, closed). Error bars repre-
sent S.D. B, the neutron values for IgG4(Ser222) are shown for 6 (M1, ƒ; M2, ;
dotted line), 20 (M1,E; M2,F; solid line), and 37 °C (M1,‚; M2,Œ; dashed line).
C, the pairs of x-ray M1 and M2 values for IgG4(Pro222) in PBS-137 (M1, ; M2,
) are compared with the data for IgG4(Ser222) depicted as lines from A.
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range of 2–6 mg/ml) and 0.8 mg/ml for IgG3 (in a range of
0.5–0.1mg/ml) (1). Although distinct immune roles for each of
the four IgG subclasses are yet to be elucidated, IgG4 is thought
to have anti-inflammatory properties, and the plasma levels of
IgG4 rise in response to repeated antigen exposure. IgG4 is
unable to activate complement via C1q binding in the comple-
ment classical pathway and binds weakly to Fc	R receptors (9).
IgG4 also has the ability to form half-mers comprising a single
FIGURE 6. Constrainedmodeling analysis for IgG4. The 20,000 goodness-of-fit R-factors are compared with the x-ray and neutron Rg values for the confor-
mationally randomized IgG4(Ser222) models. The 20,000 asymmetric and symmetric models are shown in yellow. The 10 best fit models with the lowest
R-factors are shown in green of which the best fit model is shown in pink. The experimentally observed Rg values are shown by vertical solid lines to follow the
Guinier Rg values (Table 1) with5% error ranges shown as dashed lines. A, the hydrated x-ray models are compared with the x-ray curves for IgG4(Ser
222) in
PBS-137 for each of five concentrations between 0.5 and 6 mg/ml. B, the unhydrated neutron models are compared with the neutron curve for IgG(Ser222) in
PBS-137 in 2H2O after linear extrapolation to 0mg/ml. C, the hydrated x-raymodels are comparedwith the x-ray curves for IgG4(Pro
222) in PBS-137 for each of
four concentrations between 0.5 and 2 mg/ml.
Solution Structure of IgG4
JULY 25, 2014•VOLUME 289•NUMBER 30 JOURNAL OF BIOLOGICAL CHEMISTRY 20749
 at U










pair of light and heavy chains; thus IgG4 is able to undergo
Fab-arm switching and become bispecific.
Solution Structure of Wild-type IgG4(Ser222)—For IgG4(Ser222),
our x-ray data collection involved measurement of 192 curves (or
1920 curves if time frames are included)within 2 h (Fig. 3). This high
data collection rate permitted the study of its solution structure in
different buffers as well as the comparison of the wild-type and
mutant forms. Because antibodies are considered to possess flexible
hinge structures, the use of three NaCl concentrations will test the
potential effects of flexibility on the IgG4 structure. In addition, neu-
trons permitted the studyof IgG4 inheavywater buffer at three tem-
peratures (Fig. 3).All six conditionswere replicatedusingultracentri-
FIGURE7.X-rayandneutronscatteringcurve fits for thebest fit IgG4models.A, IgG4(Ser222) fits inPBS-137byx-ray scattering.B, IgG4(Ser222) fits inPBS-137
in 2H2O extrapolated to zero concentration by neutron scattering. C, IgG4(Pro
222) fits in PBS-137 by x-ray scattering. The experimental data at 20 °C are
indicated by circles (black), and themodeled best fit scattering curve is indicated by the continuous line (red). The insets correspond to the experimental (black)
and best fit modeled (red) curves in which the M1 and M2 values are indicated by arrows.
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fugation (Fig. 1). In contrast, earlier studies reported few scattering
andultracentrifugationruns,whichlimitedtheevaluationofpotential
buffer-dependent IgG4 conformations (45–48).
Despite an expectation that flexible hinge structures would
be revealed by scattering, our wild-type IgG4(Ser222) data col-
lection indicated no observable change in the Rg, M1/M2, or
s20,w0 values in concentrations between 2 and 8 mg/ml in six
buffers and temperatures (Figs. 3 and 5). This outcome suggests
lack of conformational change in its averaged solution struc-
ture. However, below 2 mg/ml, both IgG4(Ser222) and
IgG4(Pro222) showed reproducible concentration-dependent
changes in the M2 peak that monitors the mean separation
between the Fab-Fab and Fab-Fc pairs (Fig. 5). These M2
changes were similar to those reported previously by us for
IgG4(Ser222) (20). Thus, in the most dilute conditions, the Fab
regions underwent 1–2-nm movements relative to the Fc
region to affect M2 but not the Rg or s20,w0 values. Potential
molecular mechanisms for this rearrangement are discussed
below.
The scattering modeling fits revealed asymmetric IgG4
molecular structures for the Fab and Fc regions and their con-
necting hinge in which (i) the IgG4 hinge structures are
extended in solution and (ii) the arrangement of the Fab and Fc
regions is unaffected by different buffers. IgG4 was modeled
starting from the intact IgG1 b12 molecule in which the lower
hinge was asymmetrically arranged (37). To avoid bias in our
modeling, both asymmetric and symmetric hinge structures
were tested (“Experimental Procedures”). All 10 modeling fits
showed that its Fab and Fc arrangementwas asymmetric. These
asymmetric solution structures (Figs. 6–8) are the conse-
quence of its relatively short hinge sequence and the need to
accommodate both Fab regions close to the Fc region. Thus the
hinge is too short to permit unrestricted conformations of the
Fab regions about the Fc region. The IgG4 upper hinge is 7
residues long. Its middle hinge is 5 residues long and contains
two interchain disulfide bonds. In the IgG4 models, the -car-
bon distances between the Cys220-Cys220 and Cys223-Cys223
pairs turned out to be within acceptable limits. There is evi-
dence that the inter- and intrachain disulfide bonds are in equi-
librium (13); therefore the hinge disulfide bonds are not neces-
sarily maintained intact. Even if these bonds become separated,
IgG4 remains intact due to contacts between the CH3 domain
pairs as shown by sedimentation velocity (Fig. 1). These asym-
metric solution structures resemble crystal structures for intact
IgG. Three asymmetric structures include human IgG1 b12
(Protein Data Bank code 1HZH (37)), murine IgG2a 231 (Pro-
tein Data Bank code 1IGT (53)), and murine IgG1 61.1.3 (Pro-
tein Data Bank code 1IGY (54)). A fourth hinge-deleted human
IgG1 Mcg structure, however, showed a symmetric structure
(Protein Data Bank code 1MCO (55)). Our results differ from a
previous determination of a symmetric structure for wild-type
IgG4 based on simple ellipsoid models for the Fab and Fc
regions; large differences in that study between the modeled
and experimental x-ray curves donot substantiate this symmet-
ric structure (see Fig. 4d of Ref. 45). This is in contrast to our
improved curve fits from atomistic modeling based on asym-
metric structures (Fig. 7).
After this study was completed, two crystal structures for
human IgG4 Fc were published, namely those for a recombi-
nant and a serum-derived Fc fragment (Protein Data Bank
codes 4C54 and 4C55 (56). These structures showed conforma-
tional variability around Arg409 and a unique conformation of
the FG loop in the CH2 domain when compared with human
IgG1 Fc. These two structural features were linked with the
Fab-arm exchange behavior and the reduced binding of FcRs to
IgG4, respectively. Our homology-modeled Fc structure in the
IgG4(Ser222) best fit models was compared with the IgG4 Fc
crystal structures. The rootmean square difference in-carbon
positions when superimposed was low at 0.0937 and 0.0841 nm
(Protein Data Bank codes 4C54 and 4C55, respectively). When
the Fc region in the scattering best fit model for IgG4(Ser222)
was replaced with the Fc crystal structures, the resulting R-fac-
tors of 2.7 (Protein Data Bank code 4C54) and 2.9% (Protein
Data Bank code 4C55) were almost unchanged compared with
that of 2.8% for the best fit model (Table 1).
FIGURE8.Thebest fit IgG4models.The10best fitmodels fromeachanalysis
are shownsuperimposedupon their Fc region (red).A, IgG4(Ser222) inPBS-137
(x-rays). B, IgG4(Ser222) in PBS-137 in 2H2O (neutrons). C, IgG4(Pro
222) in PBS-
137 (x-rays).
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Comparison of Wild-type and Mutant IgG4—Wild-type and
mutant IgG4 differ through the S222P substitution in its hinge.
This change to Pro abolishes half-mer formation and presum-
ably results from the reduced flexibility of the hinge (11, 12).
Our experimental data showed that the wild-type and mutant
forms had similar experimental Rg and RXS values (Table 1).
Although IgG4(Pro222) has a slightly shorter overall length at 15
nm compared with 16 nm for IgG4(Ser222), its s20,w0 value is
slightly smaller at 6.6 S compared with 6.8 S for IgG4(Ser222).
Both forms showed decreased s20,w0 values when the concentra-
tion went below 2 mg/ml. Experimentally both forms were
indistinguishable within error.
The best fit structures for IgG4(Ser222) are predominantly
asymmetric, especially at the highest concentrations (Fig. 8A).
At lower concentrations, both IgG4(Ser222) and IgG4(Pro222)
displayed a combination of asymmetric and symmetric best fit
structural models. Although the IgG4(Pro222) form is thought
to be less flexible (12), the modeling showed little difference
between the two forms. Themodeling showed that the hinge in
both IgG4 forms is mostly extended. This hinge length is mea-
sured by the -carbon positions of the flanking residues Val212
and Pro232 with a maximum possible length of 7.0 nm. The five
IgG4(Ser222) hinge lengths decreased slightly with increasing
concentration (Fig. 8A). In fact, each of the three final best fit
structures gave similar hinge lengths of 4.99–5.73  1.08 nm
for IgG4(Ser222) and 4.81–5.94  1.08 nm for IgG4(Pro222) in
PBS-137 and 5.58  1.10 nm for IgG4(Ser222) in PBS-137 in
heavy water.
Restricted Interaction of Human IgG4 with C1q—Our full
structuralmodels for IgG4 permit the re-evaluation of whyC1q
is not able to bind to IgG4. Initially C1q had been represented
by a sphere of the same volume as its crystal structure so that
C1q binding to its Fc binding site could be studied by classic
solvent accessibility calculations (20, 57). This simplified
approach suggested that the Fab regions in IgG4 obstructed the
IgG4 interaction with C1q. Here we performed molecular
docking of the Fc and C1q crystal structures to re-evaluate this
interaction. This approach had previously shown that the rab-
bit IgG interaction with C1q was allowed (19, 50).
The reactivity of complement C1q with the four human IgG
subclasses correlates with hinge length in the order IgG3 
IgG1  IgG2  IgG4) (1). Given that human IgG4 with the
shortest hinge length does not activate complement, this
implies that the hinge length is also important for activation.
Human IgG residues implicated in C1q binding include Asp270,
Lys322, Pro329, and Pro331 in the Fc region (58, 59). This C1q
binding site occurs at the top of the CH2 domain in the Fc
region. The Fab regions in both our IgG4(Ser222) and
IgG4(Pro222) models are positioned close to the IgG4 binding
site for C1q, potentially hindering C1q binding. Docking stud-
ies were performed using a shape complementarity method by
the PatchDock server (19). This was based on the 19C1q and 12
Fc contact residues identified for the IgG1-C1q complex (see
Table 2 in Ref. 50). It should be noted that 2 residues were
substituted in IgG4 when compared with IgG1 (His268 with
Gln268 and Pro331 with Ser331, denoted as Gln262 and Ser325,
respectively, in supplemental Fig. S2). In contrast to the rabbit
IgG-C1q interaction, our docked IgG4-C1q structures (Fig. 9,A
and B) show that the C1q head is sterically hindered by the Fab
regions from interacting with the top of the Fc region in IgG4.
In addition, biochemical studies using domain-switched chi-
meric antibodies showed that the differential complement acti-
vation of the subclasses resided in the COOH-terminal CH2
domain (60). Mutagenesis studies showed that Ser331 in IgG4
was critical for the inability of IgG4 to bind C1q and activate
complement. Interestingly, the strength of C1q binding to IgG4
was distinct from its ability to activate complement; thus
changes in other parts of IgG4 may be necessary for effective
complement activation (61). In conclusion, a combination of
steric hindrance from the Fab regions in IgG4, the restricted
movement of the IgG4 hinges, and the importance of Ser331 for
the Fc-C1q interaction appear to account for the lack of binding
of C1q to IgG4. The unique conformation of the FG loop in the
CH2 domains in the crystal structure of IgG4-Fc on which
Ser331 is located is likely to be relevant too (56).
Restricted Interaction of Human IgG4 with Fc	R—Many dis-
tinct Fc	Rs are present on immune cells, including monocytes,
neutrophils, platelets, and lymphocytes (1), with diverse func-
tions within the immune system. In general, Fc	R binding to
IgG activates antibody-dependent cell-mediated cytotoxicity
events, although individual Fc	Rs may have activator or inhib-
itor effects. Differences between the activities of the four IgG
subclasses are attributed to their individual affinity for specific
Fc	Rs, hence stimulating a specific and predictable response to
certain pathogens (62). The affinities of the four human IgG
FIGURE 9. Superimposition of the best fit IgG4models with C1q and FcR.
The 10 best fit models are shown superimposed upon their Fc region (red)
upon which the C1q globular head (yellow; Protein Data Bank code 1PK6) (A
and B) or the Fc (red)-Fc	RIII (cyan) complex (Protein Data Bank code 1E4K) (C
and D) are also superimposed. Other Fc-FcR crystal structures (Protein Data
Bank codes 1T83 and 1T89) give similar views (not shown). A, C1q head with
the x-ray models for 5.8 mg/ml IgG4(Ser222) in PBS-137. B, C1q head with the
x-ray models for 2.0 mg/ml IgG4(Pro222) in PBS-137. C, Fc	RIII with the x-ray
models for 5.8mg/ml IgG4(Ser222) in PBS-137.D, Fc	RIII with the x-raymodels
for 2.0 mg/ml IgG4(Pro222) in PBS-137.
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subclasses for specific Fc	Rs (Fc	RI, Fc	RII, and Fc	RIII) differ
due to different contact residues in the Fc fragment and the
Fc	Rs. Although there is only one high affinity Fc	RI receptor,
Fc	RII and Fc	RIII form two families of low affinity receptors
together with polymorphic variants as follows: Fc	RIIA (His/
Arg131 allotypes), Fc	RIIB/Fc	RIIC, Fc	RIIIA (Phe/Val158
allotypes), and Fc	RIIIB (three allelic variants termed NA1
(Arg36, Asn65, Asp82, and Val106), NA2 (Ser36, Ser65, Asn82, and
Ile106), and SH (Ser36, Ser65, Ala78, Asn82, and Ile106)). The affin-
ity constants (KA) for binding of the four IgG subclasses with all
nine Fc	R variants have been established (63). For Fc	RI, IgG1
and IgG3 bind most strongly (KA values of 6.5 and 6.1  107
M	1, respectively), IgG4 binding is slightly weaker (3.4  107
M	1), and IgG2 displayed no measureable binding. For the
remaining Fc	RII and Fc	RIII subclasses, IgG4 showed low
affinity binding with KA values near 2  107 M	1 for Fc	RIIA
(His/Arg131), Fc	RIIB/Fc	RIIC, and Fc	RIIIA (Phe/Val158)
and no measureable binding to Fc	RIIIB (NA1, NA2, and SH
allelic variants). In contrast, IgG1 and IgG3 bound to all the
Fc	RII and Fc	RIII subclasses and allelic variants often with
higherKA values ranging between 1.2 105 and 9.8 106 M	1.
Conversely, IgG2 showed mostly lower affinities than IgG1,
IgG3, and IgG4 for all Fc	Rs, including no measurable binding
for Fc	RIIIB (63).
The IgG Fc residues implicated in Fc	R binding include
Leu234-Leu235-Gly236-Gly236-Gly237-Pro238 of the lower hinge
region (64). The Fc glycan interactionswith Fc	R are important
to stabilize the interaction (65, 66). A 1:1 stoichiometry of this
interaction has been determined by sedimentation equilibrium
(67, 68). The ability of IgG to bind two Fc	R molecules may be
sterically hindered due to a conformational change upon bind-
ing of the first Fc	R molecule (69). Crystal structures of the
IgG1 Fc-Fc	RIIIB complex show that Fc	R binds to the top of
the Fc region close to the hinge (51, 52). The corresponding
IgG4-Fc	R interaction was revealed by superimposition of our
best fit IgG4(Ser222) and IgG4(Pro222) solution structures on
these crystal structures. This showed that Fc	Rbinding appears
to be permitted. Given that the Fab regions in our IgG4models
are close to the top of the Fc regionwhere the Fc	Rs bind, these
Fab regions may offer steric hindrance to binding (Fig. 9, C and
D). However, as IgG4 is able to bind most Fc	Rs (albeit not as
strongly as the IgG1 and IgG3 subclasses), a small movement of
the Fab region in our IgG4 models may permit binding to take
place, and the strength of binding between Fc and Fc	Rmay be
primarily determined by the residues present in the hinge and
CH2 domains. In this context, IgG4 possesses Phe234 in com-
parison with IgG1 and IgG3 in which this is Leu234 and with
IgG2, which has a shorter lower hinge region with Val234 and
Ala236 substitutions and the deletion of Leu235. IgG4 also has a
shorter overall hinge length, which may lead to weaker Fc	R
binding (70). The higher affinity of IgG4 for Fc	RI may be due
to an additional extracellular domain in comparison with the
two in Fc	RII and Fc	RIII or structural differences in this addi-
tional domain, leading to its greater affinity (71).
Stability of Human IgG4—Antibody stability is a major con-
cern in the context of the $30 billion antibody industry. Sta-
bilities may be compromised during manufacturing, shipping,
and storage (72). In the context of bioprocessing, the internal
stability of human IgG4 was explored here using different buf-
fers and temperatures by x-ray and neutron scattering. The
movement of the M2 peaks below 2 mg/ml confirmed our ear-
lier observations (20). This M2 shift revealed an internal struc-
tural rearrangement of the Fab and Fc regions, although here
we were not able to model this. In addition, our x-ray and neu-
tron data showed that this rearrangementwas stabilized at con-
centrations higher than 2mg/ml (Fig. 5). As similarmovements
of M2 were seen in different NaCl concentrations, this indi-
cated that charge effects within IgG4 or between IgG4 mole-
cules were not responsible for this change. The M2 peak shifts
may relate to a diffusion-collision phenomenon (which would
be charge-independent) in which more frequent collisions
between IgG4molecules at higher concentrationswould lead to
a more compact molecular conformation for IgG4. Alterna-
tively the M2 peak shifts may relate to Fab-arm exchange in
which the half-mers in IgG4 are more likely to rearrange them-
selves and dissociate in dilute conditions, leading to conforma-
tional instabilities.
To understand better how a diffusion-collision process
might lead to conformational change in IgG4, this process can
be considered as an equilibriumwhere collisions between IgG4
molecules at higher concentrations lead to a deformed shape
that can relax back to the unperturbed shape in dilute solution.
Above 2 mg/ml, the rate of collisions (kcoll) would be greater
than the relaxation rate, leading to a deformed IgG4 structure.
The upper limit for the relaxation rate is therefore defined by
the collision rate constant kcoll for 2 mg/ml. The collisional
frequency Z can be calculated using the diffusion coefficient







where N is Avogadro’s number (6.02214  10	23), D is the
diffusion coefficient (4.07  10	11 m2 s	1), and r is the radius
for two IgG4 monomers A and B. This gives a collision fre-
quency of 6300 M	1 s	1. The kcoll value can be calculated from
Equation 5.
kcoll Zp exp  EactRT  (Eq. 5)
If the transmission factor p is 1 (i.e. collisions between mole-
cules always lead to a conformational change) and Eact is 0, then
the equation is simplified to kcoll Z. At 2 mg/ml (14 M), the
upper limit for the relaxation rate is obtained by multiplying
kcoll by the concentration to give 88 s	1. Because the calculation
assumes that all collisions lead to a shape change, which is
unlikely, the true rate of relaxation will be lower than 88 s	1.
Fab-arm exchange through half-mer formation leads to
bispecificity in human IgG4 (7). This process leads to the
exchange of therapeutic IgG4molecules with endogenous IgG4
molecules in vivo (8). Fab-arm exchange was shown to be a
dynamic process (17), and themechanismof Fab-arm exchange
is controlled by local redox conditions (18). Human IgG4 also
can exchangewith isolated IgG4 Fc fragments, indicating that it
is the Fc region that is important for Fab-arm exchange (10).
Half-mer was observed for both IgG4(Ser222) and IgG4(Pro222)
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by non-reducing SDS-PAGE as a faint band at 75 kDa (sup-
plemental Fig. S3). However, these bands have been shown to
be artifacts formed under the harsh conditions of SDS-PAGE
and depend on heating times and the SDS buffers (73). No half-
mer peaks were directly observed in this study by gel filtration
or analytical ultracentrifugation (Fig. 1). This indicated that
Fab-arm exchange via half-mer formation is slow, but the half-
mer life time is short. The lowpopulation of half-merwould not
be visible by our gel filtration or analytical ultracentrifugation
experiments. The movement of the M2 peaks in dilute condi-
tions may predispose the IgG4 molecules to exchange half-
mers, perhaps following collisions between two different IgG4
molecules.
Another aspect relevant to antibody bioprocessing relates
to IgG4 dimer formation and self-association. Extensive
dimer formation may lead to nonspecific antibody aggrega-
tion. Indeed, rabbit IgGwas observed to form asmuch as 25%
dimer in heavy water buffers, possibly arising through Fab-
Fab pairings between the two monomers (19). The low
amount of IgG4 dimer observed by sedimentation velocity in
six different buffers (Fig. 1) showed that IgG4 does not
undergo extensive buffer-dependent dimerization. The
dimer peak has an s20,w0 value of about 10 S, suggesting that
dimers may arise from a compact association of the Fab and
Fc regions. However, a concentration-dependent reaction
boundary was observed for IgG4(Ser222) in heavy water,
especially at reduced temperature (Fig. 1B). This indicated
fast on/fast off association rates between monomer and
dimer. Neutron scattering confirmed the temperature-de-
pendent self-association in heavy water (Fig. 3B). Greater
dimer formation in heavy water is attributed to weaker
hydrogen bonding in this solvent, meaning that protein-pro-
tein interactions are promoted. In other studies, IgG4 has
been shown to associate with the Fc fragments of other IgG
classes, probably occurring between their CH3 domains (10).
The self-association of IgG4 molecules through the CH3
domains may be an intermediate before half-mer swapping.
IgG4 can also associate with IgG1 following a conforma-
tional change of IgG1 that exposes the IgG1 CH3 domains
(3). We conclude that dimer formation and self-association
events may be relevant to the bioprocessing properties of
IgG4.
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